Abstract: Concepts and technologies are described herein for a software builder. According to the concepts and technologies disclosed herein, a development platform can execute a software builder. The development system can receive input for creating a mobile application. In response to receiving the input, the development system can create build assets associated with the mobile application. The build assets can include components of the mobile application. The development system also can validate the build assets, store the build assets at a data storage location, compile the assets, and output the mobile application.

Abstract: Concepts and technologies are described herein for a software builder. According to the concepts and technologies disclosed herein, a development platform can execute a software builder. The development system can receive input for creating a mobile application. In response to receiving the input, the development system can create build assets associated with the mobile application. The build assets can include components of the mobile application. The development system also can validate the build as sets, store the build assets at a data storage location, compile the assets, and output the mobile application.

Abstract: Techniques are provided herein for receiving at a first network device, a virtual local area network (VLAN) discovery frame from a second network device. The second network device is configured to encapsulate Fiber Channel over Ethernet. The hardware media access control (MAC) address or Port World Wide Name (PWWN) of the second network device is extracted from the VLAN discovery frame. A mapping is identified between the second network device and a corresponding virtual storage area network (VSAN) based on the hardware MAC address or PWWN. The mapping identifies a corresponding VLAN for the second network device to use for login in order to communicate with the corresponding VSAN. Information representing the identified VLAN is sent to the second network device.

Abstract: Replicas of a database are synchronized. A failure of update data is detected from a first replica to be applied to a second replica. A cause of the failure is determined. The cause of the failure is resolved. The replicas of the database are synchronized without requiring manual intervention.

Abstract: Techniques are provided herein for receiving at a first network device, a virtual local area network (VLAN) discovery frame from a second network device. The second network device is configured to encapsulate Fiber Channel over Ethernet. The hardware media access control (MAC) address or Port World Wide Name (PWWN) of the second network device is extracted from the VLAN discovery frame. A mapping is identified between the second network device and a corresponding virtual storage area network (VSAN) based on the hardware MAC address or PWWN. The mapping identifies a corresponding VLAN for the second network device to use for login in order to communicate with the corresponding VSAN. Information representing the identified VLAN is sent to the second network device.

Abstract: Replicas of a database are synchronized. A failure of update data is detected from a first replica to be applied to a second replica. A cause of the failure is determined. The cause of the failure is resolved. The replicas of the database are synchronized without requiring manual intervention.

Abstract: A system for synchronizing replicas of a database. The system detects a failure of update data from a first replica to be applied to a second replica and determines a cause of the failure. The system also resolves the cause of the failure. According to the system disclosed herein, the present invention synchronizes the replicas of the database without requiring manual intervention.

Abstract: A method for synchronizing replicas of a database. The method includes detecting a failure of update data from a first replica to be applied to a second replica; determining a cause of the failure; and resolving the cause of the failure. According to the method disclosed herein, the present invention synchronizes the replicas of the database without requiring manual intervention.

Abstract: A system for synchronizing replicas of a database. The system detects a failure of update data from a first replica to be applied to a second replica and determines a cause of the failure. The system also resolves the cause of the failure. According to the system disclosed herein, the present invention synchronizes the replicas of the database without requiring manual intervention.

Abstract: A method and system for synchronizing replicas of a database. The method includes detecting a failure of update data from a first replica to be applied to a second replica; determining a cause of the failure; and resolving the cause of the failure. According to the method and system disclosed herein, the present invention synchronizes the replicas of the database without requiring manual intervention.

Abstract: The present invention relates to methods of treating Alzheimer's disease, and other diseases, and/or inhibiting beta-secretase enzyme, and/or inhibiting deposition of A beta peptide in a mammal, by use of known compounds of formula (I) wherein R1, R2, R3, U?, U?, V, Y, W, Q, R? are as defined herein.

Abstract: Disclosed are compounds which inhibit &bgr;-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits &bgr;-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Abstract: Disclosed are compounds which inhibit &bgr;-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed pharmaceutical compositions comprising a compound which inhibits &bgr;-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Abstract: Disclosed are compounds which inhibit &bgr;-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed pharmaceutical compositions comprising a compound which inhibits &bgr;-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.